,6,7,8,9 All three types of vaccines are able to elicit effective anti-tumor CD8+ T cell responses in mice,6,7,15,16,17 and randomized controlled trials are beginning to show therapeutic efficacy in humans.18 The gene discussed is CD8A; the disease is neoplasm.